We are live on ! Find out more
BC

Bartlett & Co Portfolio holdings

AUM $6.16B
1-Year Est. Return 20.29%
This Fund
S&P 500
This Quarter Est. Return
-0.61%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
10 Year Est. Return
AUM
$1.99B
AUM Growth
-$18.5M
Cap. Flow
+$1.59M
Cap. Flow %
0.08%
Top 10 Hldgs %
24.67%
Holding
794
New
65
Increased
125
Reduced
177
Closed
37

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$4.32M
2
ABBV icon
AbbVie
ABBV
+$2.27M
3
XOM icon
ExxonMobil
XOM
+$1.84M
4
SLB icon
SLB Ltd
SLB
+$1.52M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$1.29M

Sector Composition

Rank Sector Weight
1 Financials 17.27%
2 Healthcare 15.98%
3 Technology 12.73%
4 Consumer Staples 10.26%
5 Industrials 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$343B
$57.7M 2.89%
737,637
-53,712
-7% -$4.32M
USB icon
2
US Bancorp
USB
$99.6B
$57.2M 2.87%
1,317,831
-27,099
-2% -$1.18M
DIS icon
3
Walt Disney
DIS
$165B
$57.1M 2.86%
500,394
-7,699
-2% -$845K
AAPL icon
4
Apple
AAPL
$4.89T
$54.5M 2.73%
1,738,836
-4,912
-0.3% -$157K
MA icon
5
Mastercard
MA
$477B
$46.1M 2.31%
493,684
-6,049
-1% -$555K
RTX icon
6
RTX Corp
RTX
$287B
$45M 2.26%
645,047
+762
+0.1% +$55.9K
TJX icon
7
TJX Companies
TJX
$170B
$44.7M 2.24%
1,352,526
+12,796
+1% +$425K
PEP icon
8
PepsiCo
PEP
$186B
$43.8M 2.2%
469,709
+5,743
+1% +$549K
AMGN icon
9
Amgen
AMGN
$203B
$42.9M 2.15%
279,489
+10,222
+4% +$1.64M
BAX icon
10
Baxter International
BAX
$11.6B
$42.9M 2.15%
1,129,275
+14,991
+1% +$560K
NVS icon
11
Novartis
NVS
$295B
$42.8M 2.14%
485,166
-7,573
-2% -$695K
BRK.B icon
12
Berkshire Hathaway Class B
BRK.B
$1.07T
$41.6M 2.09%
305,591
+9,660
+3% +$1.38M
GOOG icon
13
Alphabet (Google) Class C
GOOG
$3.9T
$40.3M 2.02%
1,526,320
+11,071
+0.7% +$297K
ABT icon
14
Abbott
ABT
$180B
$38.9M 1.95%
792,292
+7,406
+0.9% +$356K
MSFT icon
15
Microsoft
MSFT
$2.84T
$38.9M 1.95%
880,326
-24,045
-3% -$1.1M
CVS icon
16
CVS Health
CVS
$137B
$37.6M 1.88%
358,131
-162
-0% -$16.6K
MET icon
17
MetLife
MET
$61B
$36M 1.8%
720,575
-307
-0% -$14.5K
QCOM icon
18
Qualcomm
QCOM
$176B
$35.4M 1.77%
565,283
+4,023
+0.7% +$274K
XOM icon
19
ExxonMobil
XOM
$651B
$34.9M 1.75%
419,315
-21,344
-5% -$1.84M
CVX icon
20
Chevron
CVX
$388B
$34.2M 1.72%
354,925
+58
+0% +$6.09K
WFC icon
21
Wells Fargo
WFC
$261B
$33.9M 1.7%
602,220
-1,261
-0.2% -$70.3K
CFR icon
22
Cullen/Frost Bankers
CFR
$10.3B
$33.4M 1.67%
424,819
+2,213
+0.5% +$163K
GILD icon
23
Gilead Sciences
GILD
$161B
$32.7M 1.64%
279,155
+4,824
+2% +$527K
SE
24
DELISTED
Spectra Energy Corp Wi
SE
$30.7M 1.54%
943,119
+20,919
+2% +$745K
SLB icon
25
SLB Ltd
SLB
$77.8B
$29.9M 1.5%
346,387
-16,809
-5% -$1.52M

Similar funds

Bartlett & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Bartlett & Co held 794 positions worth $1.99B, down 0.92% from $2.01B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Bartlett & Co's Q2 2015 filing shows 65 new, 125 increased, 177 reduced and 37 closed positions. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 1,481 shares worth $163K. The largest sale was Procter & Gamble, an estimated $4.32M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

  • Bartlett & Co's largest Q2 2015 buy was iShares 0-1 Year Treasury Bond ETF: 1,481 shares worth $163K.
  • Bartlett & Co added most to Vanguard Total Bond Market in Q2 2015, an estimated $2.57M increase.
  • Bartlett & Co's biggest Q2 2015 reduction was Procter & Gamble, cutting an estimated $4.32M.
  • Bartlett & Co fully exited Allergan plc in Q2 2015, selling an estimated $76K.
  • Bartlett & Co's ten largest holdings make up 25% of its $1.99B portfolio in Q2 2015.
  • Bartlett & Co opened 65 new positions and closed 37 in Q2 2015.
  • Bartlett & Co's portfolio value fell 0.92% quarter-over-quarter to $1.99B.

Based on Bartlett & Co's 13F filing for Q2 2015, filed 3 Aug 2015.